USE OF IMIDAZO1,2-aPYRIDINE-3-ACETAMIDE DERIVATIVES FOR THE THERAPEUTIC TREATMENT OF NEUROPSYCHIATRIC SYNDROMES ASSOCIATED WITH DISFUNCTION OF THE NEURAL CIRCUITS OF THE BASAL GANGLIA

摘要

The invention discloses the use of imidazol[1,2-a]pyridine-3-acetamide derivatives to produce a drug for the treatment of Parkinson's disease, parkinsonian syndromes, other extrapyramidal syndromes such as those classified under the heading of 'parkinsonism plus' (Steele-Richardson-Olszewski syndrome, cortical-basal ganglionic degeneration, multi-system atrophy, Wilson's disease, Hallervorden-Spatz disease, Huntington's disease, neuroacanthocytosis), obsessive-compulsive disorders and other obsessive-compulsive syndromes, frontal and subcortical dementias.